Actively Recruiting
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-02-09
3644
Participants Needed
1
Research Sites
267 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.
CONDITIONS
Official Title
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Diagnosis of new onset early-stage (I-III), low-grade (I-II), or locally advanced solid tumor
- Historical diagnosis of primary invasive solid tumor
- Diagnosis of metastatic (stage IV) or high-grade (III-IV) disease
- Enrolled in an investigational trial in the Early Drug Development Service
- Seen in the MSK Urgent Care Center from 2021 onwards
- Completed Survivorship Patient Self-Assessment
- Adults without a history of cancer under 50 years of age
- Adults without a history of cancer 50 years of age or older
- Own an Apple iPhone with valid iOS operating system
- Have a registered MSK MyChart account and willing to download the MSK Remote Monitoring app
- Self-reported very well comprehension of written and verbal English
- Willing and able to provide informed consent and HIPAA authorization
- Scheduled to undergo bone marrow transplantation
- Diagnosed with new onset acute myeloid leukemia and scheduled for antineoplastic therapy
- Scheduled for surgery for prostate cancer
- Scheduled for lung cancer surgery
- Scheduled for total neoadjuvant therapy for locally advanced rectal cancer
- Scheduled to initiate androgen deprivation therapy for at least 12 months with specified prostate cancer diagnoses
- Scheduled to undergo chemotherapy for metastatic pancreatic cancer
- Willing and able to download the Withings Health Mate app
- Willing to provide mobile digital physiological data for at least six months up to one year following consent
You will not qualify if you...
- Unable or unwilling to successfully export and/or share physiological data (Project 1)
- Unable or unwilling to appropriately use digital platforms or devices (Project 2)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
L
Luke Pike, MD, DPhil
CONTACT
J
Jessica Scott, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here